Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Investor buys out part of Neoventa Medical
Mandate

Investor buys out part of Neoventa Medical

July 21, 2006

Investor Growth Capital and CapMan are investing in Neoventa Medical AB, a Swedish medical technology company in the field of fetal monitoring. Investor Growth Capital and CapMan will hold approximately 30% each of the share capital, while the majority of the remaining shares will be owned by SEK Företagsinvest as previous. The new ownership constellation provides the company with SEK 75 million to finance the next phase in Neoventa's growth - focusing on the American market.

Vinge acted as advisor to Neoventa Holding AB. Vinge representatives included Johan Winnerblad, Marcus Axelryd and Theresa Kovac.

Related

Vinge advises Borgo in connection with its inaugural issuance of primary capital instruments (AT1)

 Vinge has advised Borgo AB (publ) in connection with its successful issuance of primary capital instruments (so called “AT1 bonds”) in the amount of SEK 350 million with a floating rate coupon of 3-month STIBOR + 390 basis points.
January 29, 2026

Vinge advises J Bil in conjunction with the acquisition of Appelskog Bil AB

 Vinge has advised the buyer J Bil AB in conjunction with the acquisition of all shares in Appelskog Bil AB.
January 29, 2026

Vinge has advised United Lithium Corp. in connection with the acquisition of Swedish Minerals AB

 United Lithium is an exploration & development company focused on the global demand for lithium, uranium and rare earth elements.
January 29, 2026